COVID-19 vaccines: Considering sex differences in efficacy and safety

The development of SARS-CoV-2 vaccines represents a significant breakthrough for managing the COVID-19 pandemic. However, their approval process has exposed a crucial limitation in clinical trial reports—that is, a disregard for sex differences in response to vaccines. Historically, males and female...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Adelaide, Stromme, Masha, Moyassari, Shayda, Chadha, Antonella Santuccione, Tartaglia, Maria Carmela, Szoeke, Cassandra, Ferretti, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824304/
https://www.ncbi.nlm.nih.gov/pubmed/35149232
http://dx.doi.org/10.1016/j.cct.2022.106700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824304/
https://www.ncbi.nlm.nih.gov/pubmed/35149232
http://dx.doi.org/10.1016/j.cct.2022.106700

Ejemplares similares